Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Myelin plasticity in the central nervous system.
Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.
Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
The immunogenetics of multiple sclerosis. The frequency of HLA-alleles class 1 and 2 is lower in Southern Brazil than in the European population.
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Symptom Co-occurrences Associated with Smoking in Individuals with Relapsing-Remitting Multiple Sclerosis.
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).
Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.
Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers.
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
CIDP presenting as recurrent severe back pain without weakness or sensory loss.
Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction.
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
Iron uptake and transport across physiological barriers.
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®.
Astrocyte Dysfunction in Developmental Neurometabolic Diseases.
Regional Myelin and Axon Damage and Neuroinflammation in the Adult Mouse Brain After Long-Term Postnatal Vanadium Exposure.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Alterations of the human gut microbiome in multiple sclerosis.
Increasing Physical Activity and Participation in People with Multiple Sclerosis: A Review.
Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair.
Treatment of the osmotic demyelination syndrome: the earlier the better?
No evidence for increased brain iron deposition in patients with ischemic white matter disease.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
797
798
799
800
801
802
803
804
805
…
next ›
last »